Mariko S Peterson,Chester J Joyner,Jessica A Brady,Jennifer S Wood,Monica Cabrera-Mora,Celia L Saney,Luis L Fonseca,Wayne T Cheng,Jianlin Jiang,Stacey A Lapp,Stephanie R Soderberg,Mustafa V Nural,Jay C Humphrey,Allison Hankus,Deepa Machiah,Ebru Karpuzoglu,Jeremy D DeBarry,MaHPIC-Consortium,Rabindra Tirouvanziam,Jessica C Kissinger,Alberto Moreno,Sanjeev Gumber,Eberhard O Voit,Juan B Gutiérrez,Regina Joice Cordy,Mary R Galinski,Dave C Anderson,Ferhat Ay,Cristiana F A Brito,John W Barnwell,Megan DeBarry,Steven E Bosinger,Jung-Ting Chien,Jinho Choi,Anuj Gupta,Chris Ibegbu,Xuntian Jiang,Dean P Jones,Nicolas Lackman,Tracey J Lamb,Frances E-H Lee,Karine Gaelle Le Roche,Shuzhao Li,Esmeralda V S Meyer,Diego M Moncada-Giraldo,Dan Ory,Jan Pohl,Saeid Safaei,Igñacio Sanz,Maren Smith,Gregory Tharp,ViLinh Tran,Elizabeth D Trippe,Karan Uppal,Susanne Warrenfeltz,Tyrone Williams,Zerotti L Woods

Abstract:Background: Kra monkeys (Macaca fascicularis), a natural host of Plasmodium knowlesi, control parasitaemia caused by this parasite species and escape death without treatment. Knowledge of the disease progression and resilience in kra monkeys will aid the effective use of this species to study mechanisms of resilience to malaria. This longitudinal study aimed to define clinical, physiological and pathological changes in kra monkeys infected with P. knowlesi, which could explain their resilient phenotype. Methods: Kra monkeys (n = 15, male, young adults) were infected intravenously with cryopreserved P. knowlesi sporozoites and the resulting parasitaemias were monitored daily. Complete blood counts, reticulocyte counts, blood chemistry and physiological telemetry data (n = 7) were acquired as described prior to infection to establish baseline values and then daily after inoculation for up to 50 days. Bone marrow aspirates, plasma samples, and 22 tissue samples were collected at specific time points to evaluate longitudinal clinical, physiological and pathological effects of P. knowlesi infections during acute and chronic infections. Results: As expected, the kra monkeys controlled acute infections and remained with low-level, persistent parasitaemias without anti-malarial intervention. Unexpectedly, early in the infection, fevers developed, which ultimately returned to baseline, as well as mild to moderate thrombocytopenia, and moderate to severe anaemia. Mathematical modelling and the reticulocyte production index indicated that the anaemia was largely due to the removal of uninfected erythrocytes and not impaired production of erythrocytes. Mild tissue damage was observed, and tissue parasite load was associated with tissue damage even though parasite accumulation in the tissues was generally low. Conclusions: Kra monkeys experimentally infected with P. knowlesi sporozoites presented with multiple clinical signs of malaria that varied in severity among individuals. Overall, the animals shared common mechanisms of resilience characterized by controlling parasitaemia 3-5 days after patency, and controlling fever, coupled with physiological and bone marrow responses to compensate for anaemia. Together, these responses likely minimized tissue damage while supporting the establishment of chronic infections, which may be important for transmission in natural endemic settings. These results provide new foundational insights into malaria pathogenesis and resilience in kra monkeys, which may improve understanding of human infections.

Superior protection in a relapsing Plasmodium cynomolgi rhesus macaque model by a chemoprophylaxis with sporozoite immunization regimen with atovaquone-proguanil followed by primaquine

Subcutaneous Administration of a Monoclonal Antibody to Prevent Malaria.

Functional Human IgA Targets a Conserved Site on Malaria Sporozoites

Autoantibodies Inhibit Plasmodium Falciparum Growth and Are Associated with Protection from Clinical Malaria

Mapping of safe and early chemo-attenuated live Plasmodium falciparum immunization identifies immune signature of vaccine efficacy

Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection

Accelerated prime-and-trap vaccine regimen in mice using repRNA-based CSP malaria vaccine

Efficient infection of non-human primates with purified, cryopreserved Plasmodium knowlesi sporozoites

IMRAS-Immunization with Radiation-Attenuated Plasmodium Falciparum Sporozoites by Mosquito Bite: Cellular Immunity to Sporozoites, CSP, AMA1, TRAP and CelTOS

Protective effects of combining monoclonal antibodies and vaccines against the Plasmodium falciparum circumsporozoite protein

Optimization of an in vivo model to study immunity to Plasmodium falciparum pre-erythrocytic stages

IMRAS—A clinical trial of mosquito-bite immunization with live, radiation-attenuated P. falciparum sporozoites: Impact of immunization parameters on protective efficacy and generation of a repository of immunologic reagents

Sporozoite immunization: Innovative Translational Science to Support the Fight against malaria

A Head-to-Head Comparative Study of the Replication-Competent Vaccinia Virus and AAV1-Based Malaria Vaccine versus RTS,S/AS01 in Murine Models

Rhesus macaques self-curing from a schistosome infection can display complete immunity to challenge

Clinical recovery of Macaca fascicularis infected with Plasmodium knowlesi

Immunity to Plasmodium knowlesi H strain malaria in olive baboons

Establishing RTS,S/AS01 as a benchmark for comparison to next-generation malaria vaccines in a mouse model

Whole sporozoite immunization with Plasmodium falciparum strain NF135 in a randomized trial

Robust antibody and CD8+ T-cell responses induced by P. falciparum CSP adsorbed to cationic liposomal adjuvant CAF09 confer sterilizing immunity against experimental rodent malaria infection